BioSpace News Archive

Truvian Sciences (“Truvian”), a healthcare company at the intersection of diagnostics and consumer technology, today unveiled the results of a first-of-its- kind research study validating the performance and accuracy of the Easy Check COVID-19 IgM/IgG™ antibody test

Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 September 2020 of its final results for the year ended 30 June 2020, the Abcam plc Annual Report and Accounts 2020 (the “Annual Report”) have been published today and are available on the Abcam plc website at www.abcamplc.com . A copy of the Annual Report has been submitted to the National Sto

DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM – 2:30 PM Eastern). The event, which will be held virtually, will include presentations from Dexcom management and industry leaders highlighting the company’s market opportunities, business strategy, innovation efforts and long-term financial outlook. Dexcom

Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will report third quarter 2020 financial results on Monday, November 9, 2020 after the close of financial markets. Progenity’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a co

Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced it will host a Key Opinion Leader (KOL) webinar to discuss the current treatment landscape within the indications for its two lead drug candidates. Nyxol is an eye drop formulation of phentolamine entering Phase 3 clinical development for night vision dist

Prescient , a biopharma product and portfolio strategy partner, announces the recent appointment of three new senior members: Gordon Gochenauer , Dr. Priya Kar and Dr. Cameron Mackenzie . They join the e

Excision BioTherapeutics Inc., a biotechnology company developing CRISPR-based therapeutics to cure viral infectious diseases, announced today the first appointees of its Business Advisory Board and its new Interim Chief Business Officer. This group of industry veterans will help steer the company to bring lifesaving, curative medications to patients in need, as well as to build one of the strongest companies in biotech. “We are extremely for

Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX - CALTX; NASDAQ - CALT) today announced the closing of the acquisition of 62.7% of Genkyotex SA (“Genkyotex”) (Euronext Paris & Brussels: FR0013399474 - GKTX) in an off-market transaction. On August 13, 2020 , Calliditas announced that it had entered into an agreeme

The study was conducted by Jackson Laboratory in partnership with Zylö Therapeutics The animal study supports that this drug candidate has the potential to be an effective treatment for cutaneous manifestations of lupus, a significant unmet medical need

The microbiome is a rapidly growing market. Understanding the detailed roles and functions of the microbiome is important as it is linked to a multitude of critical areas from human health to environmental sustainability.